Amgen Valuation
| AMGN Stock | MXN 5,779 94.00 1.65% |
At this time, the firm appears to be overvalued. Amgen Inc shows a prevailing Real Value of 5512.98 per share. The current price of the firm is 5779.0. Our model approximates the value of Amgen Inc from analyzing the firm fundamentals such as return on equity of 1.26, and Profit Margin of 0.25 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Amgen's price fluctuation is very steady at this time. Calculation of the real value of Amgen Inc is based on 3 months time horizon. Increasing Amgen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Amgen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amgen Stock. However, Amgen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5779.0 | Real 5512.98 | Hype 5779.0 |
The intrinsic value of Amgen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Amgen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Amgen Inc helps investors to forecast how Amgen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amgen more accurately as focusing exclusively on Amgen's fundamentals will not take into account other important factors: Amgen Total Value Analysis
Amgen Inc is presently anticipated to have takeover price of 3.36 T with market capitalization of 2.46 T, debt of 37.35 B, and cash on hands of 26.3 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Amgen fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.36 T | 2.46 T | 37.35 B | 26.3 B |
Amgen Investor Information
About 80.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.58. Amgen Inc recorded earning per share (EPS) of 227.54. The entity last dividend was issued on the 14th of February 2023. Based on the analysis of Amgen's profitability, liquidity, and operating efficiency, Amgen Inc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Amgen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Amgen has an asset utilization ratio of 40.42 percent. This suggests that the Company is making 0.4 for each dollar of assets. An increasing asset utilization means that Amgen Inc is more efficient with each dollar of assets it utilizes for everyday operations.Amgen Ownership Allocation
Amgen holds a total of 533.98 Million outstanding shares. The majority of Amgen Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amgen Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amgen. Please pay attention to any change in the institutional holdings of Amgen Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Amgen Profitability Analysis
The company reported the revenue of 26.32 B. Net Income was 6.55 B with profit before overhead, payroll, taxes, and interest of 19.92 B.About Amgen Valuation
Our relative valuation model uses a comparative analysis of Amgen. We calculate exposure to Amgen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Amgen's related companies.Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. AMGEN INC operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. It employs 21500 people.
8 Steps to conduct Amgen's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Amgen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Amgen's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Amgen's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Amgen's revenue streams: Identify Amgen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Amgen's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Amgen's growth potential: Evaluate Amgen's management, business model, and growth potential.
- Determine Amgen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Amgen's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Amgen Stock Analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.